Posts Tagged ‘drug

May 06, 2024
Our Take: Walmart ends its venture into health care, saying it’s ‘not sustainable’
Read More
April 29, 2024
Our Take: Top drugmakers reveal strong performances in Q1 earnings reports
Read More
April 22, 2024
Our Take: Elevance partners with private investment firm on new payer-agnostic advanced primary care business
Read More
April 15, 2024
Our Take: Docs, hospitals, and insurers want more from Medicare. Without reform, CMS can only do so much.
Read More
April 08, 2024
Our Take: Risant Health acquires Geisinger, completing the transaction Kaiser Permanente announced a year ago
Read More
April 01, 2024
Our Take: Walgreens takes $5.8 billion 2Q impairment charge, will close more VillageMD locations
Read More
March 25, 2024
Our Take: CMS introduces new model for low-revenue, primary care-focused ACOs
Read More
March 18, 2024
Our Take: AI takes center stage at HIMSS24, with Mayo Clinic, Google, Oracle, and Microsoft among the headliners
Read More
March 11, 2024
Our Take: Fallout from Change Healthcare cyberattack reaches critical point for some providers; UHG says full functionality still over a week away
Read More
March 04, 2024
Our Take: New DOJ investigation into UnitedHealth Group, Optum focuses on potential antitrust practices
Read More
February 26, 2024
Our Take: Massachusetts’ governor says Steward Health Care should exit state ASAP
Read More
February 19, 2024
Our Take: Investments propelled Kaiser Permanente to achieve profit of $4.1 billion in 2023
Read More
February 12, 2024
Our Take: CVS Health lowers its guidance for 2024, citing medical cost trends
Read More
February 05, 2024
Our Take: Cigna agrees to sell its Medicare business to HCSC for $3.7 billion
Read More

Sign up for Our Take
the weekly strategic brief for Health Care Executives

Reach out to us

Gainey Corporate Center
8777 N Gainey Center Dr, Ste 205
Scottsdale, AZ 85258
(480) 923-0802

Sign up for Our Take
the weekly strategic brief for Health Care Executives

[contact-form-7 id="321" title="Footer Newsletter"]

Posts Tagged ‘drug

Our Take: Walmart ends its venture into health care, saying it’s ‘not sustainable’

Our Take: Top drugmakers reveal strong performances in Q1 earnings reports

Our Take: Elevance partners with private investment firm on new payer-agnostic advanced primary care business

Our Take: Docs, hospitals, and insurers want more from Medicare. Without reform, CMS can only do so much.

Our Take: Risant Health acquires Geisinger, completing the transaction Kaiser Permanente announced a year ago

Our Take: Walgreens takes $5.8 billion 2Q impairment charge, will close more VillageMD locations

Our Take: CMS introduces new model for low-revenue, primary care-focused ACOs

Our Take: AI takes center stage at HIMSS24, with Mayo Clinic, Google, Oracle, and Microsoft among the headliners

Our Take: Fallout from Change Healthcare cyberattack reaches critical point for some providers; UHG says full functionality still over a week away

Our Take: New DOJ investigation into UnitedHealth Group, Optum focuses on potential antitrust practices

Our Take: Massachusetts’ governor says Steward Health Care should exit state ASAP

Our Take: Investments propelled Kaiser Permanente to achieve profit of $4.1 billion in 2023

Our Take: CVS Health lowers its guidance for 2024, citing medical cost trends

Our Take: Cigna agrees to sell its Medicare business to HCSC for $3.7 billion

Sign up for Our Take
the weekly strategic brief for Health Care Executives

share

Reach out to us

Sign up for Our Take
the weekly strategic brief for Health Care Executives

Stay Connected

Posts Tagged ‘drug

Sign up for Our Takethe weekly strategic brief for Health Care Executives

share

Reach out to us

Sign up for Our Takethe weekly strategic brief for Health Care Executives

Stay Connected

Sign up for Our Take
the weekly strategic brief for Health Care Executives

Sign up for Our Take
the weekly strategic brief for Health Care Executives